VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,134 | -17.6% | 26,950 | +20.0% | 0.01% | -18.8% |
| Q2 2023 | $69,371 | -30.1% | 22,450 | +21.7% | 0.02% | -33.3% |
| Q1 2023 | $99,261 | +33.3% | 18,450 | +64.7% | 0.02% | +33.3% |
| Q4 2022 | $74,480 | +73.2% | 11,200 | +4.7% | 0.02% | +50.0% |
| Q3 2022 | $43,000 | +13.2% | 10,700 | +39.0% | 0.01% | +20.0% |
| Q2 2022 | $38,000 | -19.1% | 7,700 | 0.0% | 0.01% | -9.1% |
| Q1 2022 | $47,000 | -61.8% | 7,700 | -27.4% | 0.01% | -56.0% |
| Q4 2021 | $123,000 | +29.5% | 10,600 | +75.1% | 0.02% | +25.0% |
| Q3 2021 | $95,000 | +179.4% | 6,053 | +235.7% | 0.02% | +185.7% |
| Q2 2021 | $34,000 | – | 1,803 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $73,923,000 | 13.88% |
| RA Capital Management | 11,120,973 | $129,226,000 | 2.28% |
| Paradigm Biocapital Advisors LP | 629,342 | $7,313,000 | 2.09% |
| OUP Management Co., LLC | 374,714 | $4,354,000 | 1.96% |
| JOHNSON & JOHNSON | 1,074,658 | $12,488,000 | 1.42% |
| Sarissa Capital Management LP | 707,010 | $8,215,000 | 0.71% |
| Woodline Partners LP | 1,111,123 | $12,911,000 | 0.18% |
| Artal Group S.A. | 550,000 | $6,391,000 | 0.17% |
| Orbimed Advisors | 833,333 | $9,683,000 | 0.12% |
| Laurion Capital Management LP | 857,308 | $9,962,000 | 0.10% |